Gene ontology terms enriched for interacted genes |
GO terms | GO terms description | target genes enrich in GO term | p-value |
|
GO:0043029
|
T cell homeostasis |
BCL2,BCL2L11,AKT1,CASP3, |
1.12E-7 |
GO:0002260
|
lymphocyte homeostasis |
BCL2,BCL2L11,AKT1,CASP3, |
2.76E-7 |
GO:0001776
|
leukocyte homeostasis |
BCL2,BCL2L11,AKT1,CASP3, |
6.01E-7 |
GO:0001782
|
B cell homeostasis |
BCL2,BCL2L11,CASP3, |
1.25E-5 |
GO:0048872
|
homeostasis of number of cells |
BCL2,BCL2L11,AKT1,CASP3, |
1.34E-5 |
|
GO:0042325
|
regulation of phosphorylation |
BCL2,CCND2,TGFBR2,AKT1,CASP3, |
4.47E-5 |
GO:0051174
|
regulation of phosphorus metabolic process |
BCL2,CCND2,TGFBR2,AKT1,CASP3, |
5.24E-5 |
GO:0019220
|
regulation of phosphate metabolic process |
BCL2,CCND2,TGFBR2,AKT1,CASP3, |
5.24E-5 |
GO:0008633
|
activation of pro-apoptotic gene products |
BCL2,BCL2L11,AKT1, |
5.27E-5 |
GO:0018105
|
peptidyl-serine phosphorylation |
BCL2,TGFBR2,AKT1, |
9.25E-5 |
GO:0008637
|
apoptotic mitochondrial changes |
BCL2,AKT1,CASP3, |
1.05E-4 |
GO:0018209
|
peptidyl-serine modification |
BCL2,TGFBR2,AKT1, |
1.68E-4 |
GO:0048534
|
hemopoietic or lymphoid organ development |
BCL2,BMI1,TGFBR2,BCL2L11, |
2.31E-4 |
GO:0003006
|
reproductive developmental process |
BCL2,CCND2,BCL2L11,AKT1, |
2.37E-4 |
GO:0010033
|
response to organic substance |
BCL2,CCND2,TGFBR2,AKT1,CASP3, |
2.46E-4 |
GO:0002520
|
immune system development |
BCL2,BMI1,TGFBR2,BCL2L11, |
2.76E-4 |
GO:0000079
|
regulation of cyclin-dependent protein kinase activity |
CCND2,AKT1,CASP3, |
3.24E-4 |
GO:0042127
|
regulation of cell proliferation |
BCL2,BMI1,CCND2,TGFBR2,CASP3, |
3.45E-4 |
GO:0000082
|
G1/S transition of mitotic cell cycle |
BCL2,CCND2,AKT1, |
3.48E-4 |
GO:0009411
|
response to UV |
BCL2,AKT1,CASP3, |
3.87E-4 |
GO:0051726
|
regulation of cell cycle |
BCL2,CCND2,AKT1,CASP3, |
4.72E-4 |
GO:0040008
|
regulation of growth |
BCL2,TGFBR2,BCL2L11,AKT1, |
5.15E-4 |
GO:0045859
|
regulation of protein kinase activity |
CCND2,TGFBR2,AKT1,CASP3, |
5.33E-4 |
GO:0043549
|
regulation of kinase activity |
CCND2,TGFBR2,AKT1,CASP3, |
5.89E-4 |
GO:0009725
|
response to hormone stimulus |
BCL2,CCND2,TGFBR2,AKT1, |
6.39E-4 |
GO:0009628
|
response to abiotic stimulus |
BCL2,TGFBR2,AKT1,CASP3, |
6.44E-4 |
GO:0051338
|
regulation of transferase activity |
CCND2,TGFBR2,AKT1,CASP3, |
6.64E-4 |
GO:0045927
|
positive regulation of growth |
BCL2,TGFBR2,AKT1, |
7.11E-4 |
GO:0007276
|
gamete generation |
BCL2,CCND2,BCL2L11,AKT1, |
7.92E-4 |
GO:0009719
|
response to endogenous stimulus |
BCL2,CCND2,TGFBR2,AKT1, |
8.52E-4 |
GO:0008284
|
positive regulation of cell proliferation |
BCL2,BMI1,CCND2,TGFBR2, |
9.08E-4 |
GO:0043065
|
positive regulation of apoptosis |
BCL2,BCL2L11,AKT1,CASP3, |
1.01E-2 |
GO:0043068
|
positive regulation of programmed cell death |
BCL2,BCL2L11,AKT1,CASP3, |
1.03E-2 |
GO:0010942
|
positive regulation of cell death |
BCL2,BCL2L11,AKT1,CASP3, |
1.04E-2 |
GO:0051329
|
interphase of mitotic cell cycle |
BCL2,CCND2,AKT1, |
1.17E-2 |
GO:0019953
|
sexual reproduction |
BCL2,CCND2,BCL2L11,AKT1, |
1.21E-2 |
GO:0043627
|
response to estrogen stimulus |
BCL2,CCND2,TGFBR2, |
1.22E-2 |
GO:0051325
|
interphase |
BCL2,CCND2,AKT1, |
1.24E-2 |
GO:0008406
|
gonad development |
BCL2,CCND2,BCL2L11, |
1.38E-2 |
GO:0032504
|
multicellular organism reproduction |
BCL2,CCND2,BCL2L11,AKT1, |
1.45E-2 |
GO:0048609
|
reproductive process in a multicellular organism |
BCL2,CCND2,BCL2L11,AKT1, |
1.45E-2 |
GO:0014070
|
response to organic cyclic substance |
BCL2,CCND2,TGFBR2, |
1.61E-2 |
GO:0048608
|
reproductive structure development |
BCL2,CCND2,BCL2L11, |
1.75E-2 |
GO:0043085
|
positive regulation of catalytic activity |
BCL2,CCND2,TGFBR2,AKT1, |
1.76E-2 |
GO:0035239
|
tube morphogenesis |
BCL2,TGFBR2,BCL2L11, |
1.78E-2 |
GO:0045137
|
development of primary sexual characteristics |
BCL2,CCND2,BCL2L11, |
1.78E-2 |
GO:0009611
|
response to wounding |
BCL2,TGFBR2,AKT1,CASP3, |
1.85E-2 |
GO:0007005
|
mitochondrion organization |
BCL2,AKT1,CASP3, |
2.09E-2 |
GO:0009416
|
response to light stimulus |
BCL2,AKT1,CASP3, |
2.09E-2 |
GO:0044093
|
positive regulation of molecular function |
BCL2,CCND2,TGFBR2,AKT1, |
2.48E-2 |
GO:0007548
|
sex differentiation |
BCL2,CCND2,BCL2L11, |
2.50E-2 |
GO:0043434
|
response to peptide hormone stimulus |
BCL2,CCND2,AKT1, |
2.60E-2 |
GO:0006915
|
apoptosis |
BCL2,BCL2L11,AKT1,CASP3, |
2.68E-2 |
GO:0012501
|
programmed cell death |
BCL2,BCL2L11,AKT1,CASP3, |
2.79E-2 |
GO:0008544
|
epidermis development |
BCL2,AKT1,CASP3, |
3.69E-2 |
GO:0048545
|
response to steroid hormone stimulus |
BCL2,CCND2,TGFBR2, |
4.01E-2 |
GO:0045737
|
positive regulation of cyclin-dependent protein kinase activity |
CCND2,AKT1, |
4.13E-2 |
GO:0031667
|
response to nutrient levels |
BCL2,TGFBR2,AKT1, |
4.22E-2 |
GO:0007398
|
ectoderm development |
BCL2,AKT1,CASP3, |
4.30E-2 |
GO:0009314
|
response to radiation |
BCL2,AKT1,CASP3, |
4.34E-2 |
GO:0008219
|
cell death |
BCL2,BCL2L11,AKT1,CASP3, |
4.45E-2 |
GO:0016265
|
death |
BCL2,BCL2L11,AKT1,CASP3, |
4.54E-2 |
GO:0042592
|
homeostatic process |
BCL2,BCL2L11,AKT1,CASP3, |
5.03E-2 |
GO:0070227
|
lymphocyte apoptosis |
BCL2L11,AKT1, |
5.16E-2 |
GO:0035295
|
tube development |
BCL2,TGFBR2,BCL2L11, |
5.23E-2 |
GO:0009991
|
response to extracellular stimulus |
BCL2,TGFBR2,AKT1, |
5.23E-2 |
GO:0045860
|
positive regulation of protein kinase activity |
CCND2,TGFBR2,AKT1, |
5.37E-2 |
GO:0045597
|
positive regulation of cell differentiation |
BCL2,TGFBR2,AKT1, |
5.66E-2 |
GO:0048070
|
regulation of pigmentation during development |
BCL2,BCL2L11, |
5.67E-2 |
GO:0033674
|
positive regulation of kinase activity |
CCND2,TGFBR2,AKT1, |
5.76E-2 |
GO:0032270
|
positive regulation of cellular protein metabolic process |
BCL2,CCND2,AKT1, |
5.85E-2 |
GO:0030097
|
hemopoiesis |
BCL2,BMI1,TGFBR2, |
6.00E-2 |
GO:0042981
|
regulation of apoptosis |
BCL2,BCL2L11,AKT1,CASP3, |
6.11E-2 |
GO:0051347
|
positive regulation of transferase activity |
CCND2,TGFBR2,AKT1, |
6.20E-2 |
GO:0043067
|
regulation of programmed cell death |
BCL2,BCL2L11,AKT1,CASP3, |
6.28E-2 |
GO:0010941
|
regulation of cell death |
BCL2,BCL2L11,AKT1,CASP3, |
6.34E-2 |
GO:0051247
|
positive regulation of protein metabolic process |
BCL2,CCND2,AKT1, |
6.35E-2 |
GO:0051094
|
positive regulation of developmental process |
BCL2,TGFBR2,AKT1, |
8.25E-2 |
GO:0018107
|
peptidyl-threonine phosphorylation |
BCL2,TGFBR2, |
9.27E-2 |
GO:0051402
|
neuron apoptosis |
BCL2,CASP3, |
9.79E-2 |
GO:0048536
|
spleen development |
BCL2,BCL2L11, |
9.79E-2 |
|
|
|
|
|
|